KŘENEK, Pavel, Yvonne BENEŠOVÁ, Julie BIENERTOVÁ VAŠKŮ and Anna VAŠKŮ. The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study. Journal of Molecular Neuroscience. USA: Springer New York, 2018, vol. 64, No 4, p. 559-566. ISSN 0895-8696. Available from: https://dx.doi.org/10.1007/s12031-018-1034-1.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study
Authors KŘENEK, Pavel (203 Czech Republic, belonging to the institution), Yvonne BENEŠOVÁ (203 Czech Republic, guarantor, belonging to the institution), Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, belonging to the institution) and Anna VAŠKŮ (203 Czech Republic, belonging to the institution).
Edition Journal of Molecular Neuroscience, USA, Springer New York, 2018, 0895-8696.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.577
RIV identification code RIV/00216224:14110/18:00102534
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12031-018-1034-1
UT WoS 000431214500009
Keywords in English Multiple sclerosis; Single-nucleotide polymorphism; Vitamin D receptor; EDSS; MSSS
Tags 14110221, 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 11/2/2019 14:05.
Abstract
Vitamin D receptor polymorphisms have been the target of many studies focusing on multiple sclerosis. However, previously reported results have been inconclusive. The objective of this study was to investigate the association between five vitamin D receptor polymorphisms (EcoRV, Fold, ApaI, TaqI. and BsmI) and multiple sclerosis susceptibility and its course. The study was carried out as a case-control and genotype-phenotype study, consisted of 296 Czech multiple sclerosis patients and 135 healthy controls. Genotyping was carried out using polymerase chain reaction and restriction analysis. In multiple sclerosis men, allele and/or genotype distributions differed in EcoRV, TaqI, BsmI, and ApaI polymorphisms as compared to controls (EcoRV, p(a) = 0.02; Taq, p(g) = 0.02, p(a) = 0.02; BsmI, p(g) = 0.02, p(a) = 0.04; ApaI, p(g) = 0.008, p(a) = 0.005). In multiple sclerosis women, differences in the frequency of alleles and genotypes were found to be significant in ApaI (controls vs multiple sclerosis women: p(g) = 0.01, p(a) = 0.05). Conclusive results were observed between multiple sclerosis women in the case of EcoRV [differences in Expanded Disability Status Scale (p = 0.05); CT genotype was found to increase the risk of primary progressive multiple sclerosis 5.5 times (CT vs CC+ TTp(corr) = 0.01, sensitivity 0.833, specificity 0.525. power test 0.823)] and Fold [borderline difference in Multiple Sclerosis Severity Score (p = 0.05)]. Our results indicate that the distribution of investigated vitamin D receptor polymorphisms is a risk factor for multiple sclerosis susceptibility and progression in the Czech population. The association between disease risk and polymorphisms was found to be stronger in men. The association of disease progression with polymorphisms was observed only in women.
Links
MUNI/A/1426/2015, interní kód MUName: Genetická a epigenetická patofyziologie vybraných stavů (Acronym: Genetika a epigenetika)
Investor: Masaryk University, Category A
MUNI/A/1549/2014, interní kód MUName: Experimentální molekulární patofyziologie vybraných komplexních chorob/ stavů (Acronym: markery komplexních nemocí)
Investor: Masaryk University, Category A
PrintDisplayed: 4/5/2024 16:04